«It was fun to see the creativity these groups came up with for their programs in the October 2017
grant application cycle,» said Kelly Clardy, Maddie's Fund Senior Grants Specialist.
The Association provided guidance to these charters through
the grant application cycle, as well during the charter application process:
Many will tackle problems that don't fit into the regular
grant application cycle because they are too experimental or unlikely to produce results soon enough for conventional renewal requirements.
Not exact matches
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state
grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug
applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
The Massachusetts Department of Environmental Protection (MassDEP) Recycling Business Development
Grant (RBDG) program is currently accepting applications for its 2018 grant c
Grant (RBDG) program is currently accepting
applications for its 2018
grant c
grant cycle.
We have opened up the
application period for
Cycle 4 of the Partners for Breakfast in the Classroom
grant, and many of... Continue reading →
In the past, she says, the 6 - month turnaround and 6 - month
grants cycle forced many scientists to push themselves to the brink in hopes of meeting the next impossibly short
application deadline.
Kessler Foundation is currently accepting
applications for its 2012
Grant cycle.
We have opened up the
application period for
Cycle 4 of the Partners for Breakfast in the Classroom
grant, and many of... Continue reading →
Applicants will be required to submit, as part of their
application, a five - year budget, said Weikle, that shows how they plan to sustain their programs
grant - free in years four and five of the
cycle.
The 2018
Grants Cycle will open for
applications on Friday February 16th.
Grant cycle submission date:
Grant applications will be accepted starting on February 1, 2018 and close on March 1, 2018.
The Fulton County Board of Commissioners has recently opened up a new
cycle of funding, calling on artist collectives, artists, and non-profit arts organizations to submit
grant applications for up to $ 150,000 in funding for projects in Fulton County.
In its first
cycle, WaveMaker
Grants received nearly 100
applications of incredible breadth and quality.
The START Mission recommendations served as the information basis and independent expert evaluation for Egypt's subsequent
application to the Global Environmental Facility, to support the identified 140MW Integrated Solar Combined
Cycle (ISCC) power plant project at Kuraymat with a 50 Million dollar
grant under GEF - OP7.
Executive Project / Program / Healthcare Manager offering 15 + years of experience in managing implementation of healthcare insurance
applications, electronic healthcare records
applications, health information systems, revenue
cycle management, healthcare facilities and
grant funded programs
grant writing, budget management, operational improvement and project management.
Prepare technical training manuals and user guides for an online Oracle web
application for U.S. Department of Housing and Urban Development to streamline the entire 100 +
grant life
cycles.
Assist
grant managers with full
grant cycle including
application creation and release and sub-grantee reporting.
Areas of Expertise IT Management Network Engineering Citrix Engineer \ Administration Active Directory / File Security Manager VMWare Engineer \ Administration Network Design / Architecture Local Area Networks (LAN) Wide Area Networks (WAN Help Desk Management Data Center Management / Design * Altiris Administration System Automation Server Configuration Security Systems Management * Hardware Installation Software Configuration Remote Software Deployment Patch Management * Change Management Project Management Business Process Analysis Business Communications Sales / Marketing Management Risk Management / Disaster Recovery Analyst Statistical Analysis Database Management Policy Development Contract Negotiation *
Grant Writing Total Quality Management (TQM) Training & Development TCP / IP Configuration Change Management Monitoring Ability to increase organizational effectiveness and staff skill level through training and awareness of best practices Unique blend of technical experience administrative skills and team - building capabilities Mastery of all phases of project development life
cycle including requirements analysis specifications development
application design implementation data conversion design review and system testing * Proven ability to communicate effectively with all involved parties to ensure the development of viable business solutions to technical issues Ability to manage complex systems spanning multiple platforms and multiple functionalities * Demonstrated leadership and team - building capabilities in the professional environment as well as through active community involvement * Ability to cultivate trust and respect through open communication and shared goals among various business units
Applications must be received by June 1 or December 1 to be eligible for the current
grant cycle.